The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 6, 2024 in Elanco Lawsuit - ELAN

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Elanco Animal Health Incorporated regarding a class action lawsuit alleging misleading statements and omissions related to product safety and approval timelines [1][2]. Group 1: Allegations - The complaint claims that Elanco misrepresented the safety of Zenrelia, an oral inhibitor for canine dermatology, suggesting it was safer than it actually is [1]. - It is alleged that Elanco is unlikely to meet its previously stated timeline for the U.S. approval and commercial launch of Zenrelia and Credelio Quattro, a parasiticide for dogs [1]. - The company's business and financial prospects were reportedly overstated due to these misleading statements, leading to a misrepresentation of the company's public statements [1]. Group 2: Class Action Details - The class period for the lawsuit is defined as November 7, 2023, to June 26, 2024, and shareholders are encouraged to register for participation [1][2]. - The deadline for shareholders to seek lead plaintiff status is December 6, 2024, with no cost or obligation to participate in the case [2]. Group 3: Law Firm Background - The Gross Law Firm is recognized nationally for class action lawsuits, focusing on protecting investors from deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [3].